APA (7th ed.) Citation

S, S. A., AL, G., JJ, L., H, D., DJ, T., A, W., & RA, V. (2015). Drug-associated dermatomyositis following ipilimumab therapy: A novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade. JAMA dermatology, 151(2), 195. https://doi.org/10.1001/jamadermatol.2014.2233

Chicago Style (17th ed.) Citation

S, Sheik Ali, Goddard AL, Luke JJ, Donahue H, Todd DJ, Werchniak A, and Vleugels RA. "Drug-associated Dermatomyositis Following Ipilimumab Therapy: A Novel Immune-mediated Adverse Event Associated with Cytotoxic T-lymphocyte Antigen 4 Blockade." JAMA Dermatology 151, no. 2 (2015): 195. https://doi.org/10.1001/jamadermatol.2014.2233.

MLA (9th ed.) Citation

S, Sheik Ali, et al. "Drug-associated Dermatomyositis Following Ipilimumab Therapy: A Novel Immune-mediated Adverse Event Associated with Cytotoxic T-lymphocyte Antigen 4 Blockade." JAMA Dermatology, vol. 151, no. 2, 2015, p. 195, https://doi.org/10.1001/jamadermatol.2014.2233.